Clinical Outcome of Implantable Cardioverter Defibrillators With Recalled and Non-Recalled Leads in Japanese Patients : Increased Failure Rate of The Sprint Fidelis Lead

  • Yanagisawa Satoshi
    Departments of Cardiology, Nagoya University Graduate School of Medicine Department of Cardiology, Chunichi Hospital
  • Inden Yasuya
    Departments of Cardiology, Nagoya University Graduate School of Medicine
  • Shimano Masayuki
    Departments of Cardiology, Nagoya University Graduate School of Medicine
  • Yoshida Naoki
    Departments of Cardiology, Nagoya University Graduate School of Medicine
  • Ichiyanagi Hiroshi
    Clinical Engineering, Nagoya University Graduate School of Medicine
  • Fujita Masaya
    Departments of Cardiology, Nagoya University Graduate School of Medicine
  • Ohguchi Shiou
    Departments of Cardiology, Nagoya University Graduate School of Medicine
  • Ishikawa Shinji
    Departments of Cardiology, Nagoya University Graduate School of Medicine
  • Kato Hiroyuki
    Departments of Cardiology, Nagoya University Graduate School of Medicine
  • Okumura Satoshi
    Departments of Cardiology, Nagoya University Graduate School of Medicine
  • Miyoshi Aya
    Departments of Cardiology, Nagoya University Graduate School of Medicine
  • Nagao Tomoyuki
    Departments of Cardiology, Nagoya University Graduate School of Medicine
  • Yamamoto Toshihiko
    Departments of Cardiology, Nagoya University Graduate School of Medicine
  • Hirai Makoto
    Department of Cardiology, Nagoya University Graduate School of Health Science
  • Murohara Toyoaki
    Departments of Cardiology, Nagoya University Graduate School of Medicine

書誌事項

タイトル別名
  • Clinical Outcome of Implantable Cardioverter Defibrillators With Recalled and Non-Recalled Leads in Japanese Patients
  • – Increased Failure Rate of The Sprint Fidelis Lead –

この論文をさがす

抄録

Background: In recent years, there has been a series of recalls of popular implantable cardioverter defibrillators leads, and several reports have demonstrated an increasing rate of failure of such leads over time in Caucasian patients. However, little is known about the performance of these leads in Asian patients. The aim of this study was to investigate the rate of failure of the recalled leads and the characteristics as compared with non-recalled leads in Japanese patients. Methods and Results: A retrospective chart review was conducted in 214 patients (75 Sprint Fidelis, 8 Riata, and 131 Sprint Quattro leads) who underwent implantation and follow-up at Nagoya University Hospital. During the follow-up period, 14 Sprint Fidelis leads (19%) and 1 Riata lead (13%) failed, but no abnormality was found in the Sprint Quattro, non-recalled leads. Five patients (4 Sprint Fidelis and 1 Riata, 33% of lead failure patients) received inappropriate shocks. The 3-, 4-, and 5-year lead survival rates in Sprint Fidelis leads were 95.1% (95% confidence interval [CI]: 89.6%–100%), 89.8% (95% CI: 82.1%–97.6%), and 88.0% (95% CI: 79.6%–96.4%), respectively. A previous device implantation before Sprint Fidelis lead was the only significant predictor for lead fracture (hazard ratio, 5.33; 95% CI: 1.55–18.4; P=0.008). Conclusions: The rate of Sprint Fidelis lead failure continues to increase over time in Japanese patients.  (Circ J 2014; 78: 353–359)<br>

収録刊行物

  • Circulation Journal

    Circulation Journal 78 (2), 353-359, 2014

    一般社団法人 日本循環器学会

参考文献 (25)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ